|
Nov 28
|
Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference
|
|
Nov 6
|
Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform
|
|
Nov 6
|
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis
|
|
Sep 19
|
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
|
|
Sep 1
|
Top Growth Stocks for September 2023
|
|
Sep 1
|
Top Stocks for September 2023
|
|
Aug 31
|
Wall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade
|
|
Aug 30
|
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
|
|
Aug 10
|
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
|